3B Blackbio [3BBLACKBIO] vs Dishman Carbogen [DCAL] Detailed Stock Comparison
3B Blackbio
BSE
Loading...
Dishman Carbogen
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: 3B Blackbio wins in 8 metrics, Dishman Carbogen wins in 11 metrics, with 0 ties. Dishman Carbogen appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | 3B Blackbio | Dishman Carbogen | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.06 | 40.32 | 3B Blackbio |
| Price-to-Book Ratio | 4.79 | 0.72 | Dishman Carbogen |
| Debt-to-Equity Ratio | 0.11 | 40.97 | 3B Blackbio |
| PEG Ratio | 1.91 | -0.31 | Dishman Carbogen |
| EV/EBITDA | 23.83 | 10.26 | Dishman Carbogen |
| Profit Margin (TTM) | 49.51% | 3.60% | 3B Blackbio |
| Operating Margin (TTM) | 51.98% | 8.38% | 3B Blackbio |
| EBITDA Margin (TTM) | 51.98% | 8.38% | 3B Blackbio |
| Return on Equity | 17.58% | 0.06% | 3B Blackbio |
| Return on Assets (TTM) | 16.11% | 0.03% | 3B Blackbio |
| Free Cash Flow (TTM) | $424.53M | $1.58B | Dishman Carbogen |
| 1-Year Return | 2.74% | 37.76% | Dishman Carbogen |
| Price-to-Sales Ratio (TTM) | 12.42 | 1.45 | Dishman Carbogen |
| Enterprise Value | $12.16B | $60.70B | Dishman Carbogen |
| EV/Revenue Ratio | 12.25 | 2.10 | Dishman Carbogen |
| Gross Profit Margin (TTM) | 75.00% | 86.15% | Dishman Carbogen |
| Revenue per Share (TTM) | $116 | $188 | Dishman Carbogen |
| Earnings per Share (Diluted) | $57.31 | $6.65 | 3B Blackbio |
| Beta (Stock Volatility) | 0.28 | 0.17 | Dishman Carbogen |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
3B Blackbio vs Dishman Carbogen Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| 3B Blackbio | 1.64% | -11.51% | -1.70% | -25.19% | -20.50% | -27.08% |
| Dishman Carbogen | -2.90% | 6.31% | 11.88% | 2.89% | 29.89% | -1.95% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| 3B Blackbio | 2.74% | 80.63% | 80.63% | 80.63% | 80.63% | 80.63% |
| Dishman Carbogen | 37.76% | 132.64% | 50.89% | 119.58% | 181.95% | 287.20% |
Performance & Financial Health Analysis: 3B Blackbio vs Dishman Carbogen
| Metric | 3BBLACKBIO | DCAL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹12.33B | ₹42.04B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 11,965 | 127,268 |
| 90 Day Avg. Volume | 8,132 | 103,577 |
| Last Close | ₹1,436.75 | ₹271.65 |
| 52 Week Range | ₹1,253.80 - ₹2,350.00 | ₹161.21 - ₹307.98 |
| % from 52W High | -38.86% | -11.80% |
| All-Time High | ₹2,350.00 (Dec 09, 2024) | ₹396.40 (Jan 22, 2018) |
| % from All-Time High | -38.86% | -31.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.35% |
| Quarterly Earnings Growth | 0.13% | 0.35% |
| Financial Health | ||
| Profit Margin (TTM) | 0.50% | 0.04% |
| Operating Margin (TTM) | 0.52% | 0.08% |
| Return on Equity (TTM) | 0.18% | 0.00% |
| Debt to Equity (MRQ) | 0.11 | 40.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹299.81 | ₹372.17 |
| Cash per Share (MRQ) | ₹14.62 | ₹33.89 |
| Operating Cash Flow (TTM) | ₹619.97M | ₹-187,700,000 |
| Levered Free Cash Flow (TTM) | ₹476.52M | ₹32.40M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: 3B Blackbio vs Dishman Carbogen
| Metric | 3BBLACKBIO | DCAL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.06 | 40.32 |
| Forward P/E | N/A | 21.45 |
| PEG Ratio | 1.91 | -0.31 |
| Price to Sales (TTM) | 12.42 | 1.45 |
| Price to Book (MRQ) | 4.79 | 0.72 |
| Market Capitalization | ||
| Market Capitalization | ₹12.33B | ₹42.04B |
| Enterprise Value | ₹12.16B | ₹60.70B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.25 | 2.10 |
| Enterprise to EBITDA | 23.83 | 10.26 |
| Risk & Other Metrics | ||
| Beta | 0.28 | 0.17 |
| Book Value per Share (MRQ) | ₹299.81 | ₹372.17 |
Financial Statements Comparison: 3B Blackbio vs Dishman Carbogen
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | 3BBLACKBIO | DCAL |
|---|---|---|
| Revenue/Sales | ₹222.35M | ₹7.16B |
| Cost of Goods Sold | ₹55.60M | ₹1.46B |
| Gross Profit | ₹166.75M | ₹5.70B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹115.57M | ₹736.00M |
| EBITDA | ₹161.51M | ₹1.61B |
| Pre-Tax Income | ₹158.64M | ₹277.00M |
| Income Tax | ₹32.19M | ₹-153.90M |
| Net Income (Profit) | ₹126.45M | ₹430.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | 3BBLACKBIO | DCAL |
|---|---|---|
| Cash & Equivalents | ₹124.73M | ₹3.41B |
| Total Current Assets | ₹1.32B | ₹22.00B |
| Total Current Liabilities | ₹185.88M | ₹19.25B |
| Long-Term Debt | ₹3.07M | ₹13.90B |
| Total Shareholders Equity | ₹2.71B | ₹58.32B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹72.19M | ₹29.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | 3BBLACKBIO | DCAL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | 3BBLACKBIO | DCAL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 11,965 | 127,268 |
| Average Daily Volume (90 Day) | 8,132 | 103,577 |
| Shares Outstanding | 8.58M | 156.78M |
| Float Shares | 2.62M | 55.23M |
| % Held by Insiders | 0.65% | 0.71% |
| % Held by Institutions | 0.02% | 0.02% |
Dividend Analysis & Yield Comparison: 3B Blackbio vs Dishman Carbogen
| Metric | 3BBLACKBIO | DCAL |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |